Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction
- 1 January 1994
- journal article
- Published by Elsevier in The Lancet
- Vol. 343 (8891) , 196-200
- https://doi.org/10.1016/s0140-6736(94)90988-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction [see comments]Blood, 1991
- Immunoglobulin gene ‘fingerprinting’: an approach to analysis of B lymphoid clonality in lymphoproliferative disordersBritish Journal of Haematology, 1991
- Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias.Journal of Clinical Investigation, 1990
- Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms.Proceedings of the National Academy of Sciences, 1990
- Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B‐lymphocyte clones in a polyclonal populationBritish Journal of Haematology, 1990
- Monoclonality in B-lymphoproliferative disorders detected at the DNA levelBlood, 1990
- Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens.Journal of Clinical Pathology, 1990
- Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequencesBlood, 1989
- Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes.Proceedings of the National Academy of Sciences, 1989
- Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA PolymeraseScience, 1988